latest news releases from the newsroom
Generex Biotechnology Corp.
Generex Biotechnology Inks Glucose RapidSpray Distribution Deal in Brazil
WORCESTER, Mass., Aug. 21, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, has entered into a product licensing and distribution agreement with ABP-Comercio, Importacao E Exportacao Ltda. (www.abptrade.com.br) for the registration, importation, marketing, distribution, and sale in Brazil of Glucose RapidSpray(tm) (www.glucoserapidspray.com), the Company's proprietary glucose buccal spray product.
Merit Medical Systems, Inc.
Merit Medical to Present At Thomas Weisel Partners Healthcare Conference
SOUTH JORDAN, Utah, Aug. 21, 2008 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, today announced that it will present at the Thomas Weisel Partners Healthcare Conference being held September 3-5, 2008 at the Four Seasons Hotel in Boston.
Sterling County, Texas Sheriff's Department Selects COPsync's Technology Platform
CANYON LAKE, Texas, Aug. 21, 2008 (GLOBE NEWSWIRE) -- COPsync, Inc. (OTCBB:COYN), a software technology provider to law enforcement and emergency service professionals, announced today that it has been awarded a contract to provide the Sterling County, Texas Sheriff's Department with the Company's software technology platform, COPsync(tm).
School Specialty, Inc
School Specialty Reports Fiscal 2009 First Quarter Results
GREENVILLE, Wis., Aug. 21, 2008 (GLOBE NEWSWIRE) -- School Specialty (Nasdaq:SCHS), a leading education company providing supplemental learning products to the pre K-12 market, today reported fiscal 2009 first quarter financial results. The company reported first quarter revenue of $378.8 million, a 2 percent decline from the prior-year's $386.5 million. Earnings from continuing operations were $35.1 million compared with $40.6 million reported in last year's first quarter. Diluted earnings per share from continuing operations were $1.84 compared with $1.87 last year.